AXLN was first mentioned as one of my favorite biotech short trade ideas back on Oct 21st.  The trade was also covered in the recent biotech short trade ideas video and once again looks to be offering an objective short entry or add-on at current levels as it re-tests the former first target level from below (as well as the 200ema).  A stop above the 97.50 level would offer an very nice R/R of 6:1 on this trade as T2 (69.60) would be the price target.